Synthesis of phosphonate derivatives of 2,3-dihydroindene

doi:10.1016/j.tetlet.2009.10.042

Tetrahedron Letters

Volume 50, Issue 52, 30 December 2009, Pages 7314-7317

https://doi.org/10.1016/j.tetlet.2009.10.042 Get rights and content

Abstract

Simple and convenient procedures for the synthesis of derivatives of 2,3-dihydroinden-2-ylphosphonic acid are developed. The reaction strategies utilize both functionalization of the already existing 2,3-dihydroindene skeleton and an annulation reaction starting from readily available o-disubstituted benzene derivatives.

Graphical abstract

References and notes (28)

S. Kotha et al.
Tetrahedron Lett.
(1997)
S. Kotha et al.
Bioorg. Med. Chem.
(2002)
Oshiro, Y.; Ueda, H.; EP 173331, 1986; Chem. Abstr. 1986, 105,...
Noda, K.; Nakagawa, A.; Yamagata, K.; Nakashima, Y.; Tsuji, M.; Aoki, T.; Ide, H. U.S. Patent 4443626, 1984; Chem....
F. Fülöp et al.
Pure Appl. Chem.
(2004)
L.-M. Yang et al.
Bioorg. Med. Chem. Lett.
(1995)
Neubert, T.; Kawatkar, A. S.; Martinborough, E.; Termin, A. WO/2006/133459 Patent, 2006; Chem. Abstr. 2007, 146,...
N. Sharaf El Din
Acta Pharm.
(1999)
O.F. Arp et al.
J. Am. Chem. Soc.
(2005)
A.R. Kazemizadeh et al.
J. Braz. Chem. Soc.
(2009)

C.E. Griffin et al.

J. Org. Chem.

(1959)

S.J. Gharpure et al.

Synlett

(2007)

D. Basavaiah et al.

Synthesis

(2001)

A. Roy et al.

ARKIVOC

(2005)

Cited by (13)

Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity
2022, European Journal of Medicinal Chemistry
Citation Excerpt :
All final compounds are >95% pure by elemental analysis on a PerkinElmer 240-B analyser, for C, H, and N, and for representative compounds, 6 and 14, by High Performance Liquid Chromatography (HITACHI Primaide HPLC, 1 mL/min flow, 90% linear gradient of solvent A (acetonitrile) in B (water)). Compound 20 was synthesized as reported in literature [32]. To a solution of ethyl acetoacetate (0.397 g, 3.1 mmol, 1.2 eq) in THF (3 mL) at 0 °C was slowly added NaH 60% in mineral oil (1.5 eq).
A small library of novel 1,3,4-oxadiazole bioisosteres was synthesized and their cytotoxic activity evaluated in vitro. Five of the new derivatives (3, 6, 11, 14 and 15) showed high potency against different human cancer cell lines, with 14 being the most interesting compound endowed with IC₅₀ ranging from 0.005 to 0.091 μM. Preliminary SAR studies have suggested that the-chlorine atom in ortho position of the phenyl ring on the 1,3,4-selenadiazole is important for antitumor potency in vitro. Notably, these new compounds showed stronger anti-tumor activity than the previously synthesized and published oxadiazole lead compound 2. Furthermore, the cytotoxic effect was only relevant in tumor cells compared to human primary cells. These results suggest that the nature of the selenadiazole and thiadiazole rings may be even more important for antitumor potency in vitro than the nature of the previously described oxadiazole. All five compounds resulted in a G2/M arrest of the cell cycle and activated an apoptotic response. The colony formation assay showed the long-term effect of the compounds on tumor lines in vitro. Immunofluorescence analysis of β-tubulin indicated that all compounds interacted with micro-tubulin organization and mitotic spindle formation causing aberrant cell formation. For these reasons, the new molecules 3, 6, 11, 14 and 15 could be good candidates in preventive and chemotherapeutic strategies.
N-alkylpiperidine carbamates as potential anti-Alzheimer's agents
2020, European Journal of Medicinal Chemistry
Citation Excerpt :
N-(2,3-dihydro-1H-inden-2-yl) piperidine alcohols 52–55 were prepared in modest yields (21–33%) by alkylating the nitrogen of starting piperidines 40–43 with 2-bromo-2,3-dihydro-1H-indene (56) in the presence of K2CO3 and a catalytic amount of KI in MeCN at reflux. Bromide 56 was prepared from 2,3-dihydro-1H-inden-2-ol (57) and bromine in the presence of triphenylphosphine in CH2Cl2 [35] in 83% yield. The designed phenyl carbamates 4–15 and 4-isopropylphenyl carbamates 16–27 were synthesized in high yields (85–96%) by treating N-alkyl alcohols 44–55 with phenyl isocyanate or 4-isopropylphenyl isocyanate in the presence of a catalytic amount of N,N-dimethylpyridin-4-amine (4-DMAP) in CH2Cl2 at room temperature [36].
Compounds capable of interacting with single or multiple targets involved in Alzheimer’s disease (AD) pathogenesis are potential anti-Alzheimer’s agents. In our aim to develop new anti-Alzheimer’s agents, a series of 36 new N-alkylpiperidine carbamates was designed, synthesized and evaluated for the inhibition of cholinesterases [acetylcholinesterase (AChE) and butyrylcholinesterase (BChE)] and monoamine oxidases [monoamine oxidase A (MAO-A and monoamine oxidase B (MAO-B)]. Four compounds are very promising: multiple AChE (IC₅₀ = 7.31 μM), BChE (IC₅₀ = 0.56 μM) and MAO-B (IC₅₀ = 26.1 μM) inhibitor 10, dual AChE (IC₅₀ = 2.25 μM) and BChE (IC₅₀ = 0.81 μM) inhibitor 22, selective BChE (IC₅₀ = 0.06 μM) inhibitor 13, and selective MAO-B (IC₅₀ = 0.18 μM) inhibitor 16. Results of enzyme kinetics experiments showed that despite the carbamate group in the structure, compounds 10, 13, and 22 are reversible and non-time-dependent inhibitors of AChE and/or BChE. The resolved crystal structure of the complex of BChE with compound 13 confirmed the non-covalent mechanism of inhibition. Additionally, N-propargylpiperidine 16 is an irreversible and time-dependent inhibitor of MAO-B, while N-benzylpiperidine 10 is reversible. Additionally, compounds 10, 13, 16, and 22 should be able to cross the blood-brain barrier and are not cytotoxic to human neuronal-like SH-SY5Y and liver HepG2 cells. Finally, compounds 10 and 16 also prevent amyloid β_1–42 (Aβ_1–42)-induced neuronal cell death. The neuroprotective effects of compound 16 could be the result of its Aβ_1–42 anti-aggregation effects.
A substitution/dynamic kinetic resolution - Asymmetric transfer hydrogenation tandem process for preparation of stereocenters Β-hydroxy sulfones
2018, Molecular Catalysis
Citation Excerpt :
By screening a series of N–(4–methyl)benzenesulfonylated 1,2–diphenylethylenediamine (TsDPEN)–based η6–areneRu complexes and η5–Cp*M complexes (Cp* = pentamethylcyclopentadiene) [29–31], η6–mesityleneRuTsDPEN complex could behave efficiently as an optimal catalyst in substitution/DKR–ATH tandem process, furnishing optically pure 1,2–position stereocenters β-hydroxy sulfones with high yields, enantioselectivities (92–99% ee) and diastereomeric ratios (up to 99:1) under mild reaction conditions (shown in Scheme 1). At the outset of our research, the α–bromoindenones and 2-bromo-3,4-dihydronaphthalen-1(2H)-one were prepared according to the published procedures [32]. All other chemicals and solvents were of analytic grade and used as received except as specified.
A noval method for the synthesis of optically active β-hydroxy sulfones was developed. Through a substitution/dynamic kinetic resolution–asymmetric transfer hydrogenation, the presented method was based on one-pot enantioselective organic transformations of α–bromoindenones and sodium arylsulfinate. The protocol employed RuCl₂[(S,S)–TsDPEN](mesitylene) as a catalyst, and sodium formate as a hydrogen source, affording various optically pure vicinal stereocenters β-hydroxy sulfones in high yields with excellent enantioselectivities (up to 99%) and diastereomeric ratios (up to 99:1) under mild reaction conditions.
Acetyl Bromide Promoted Sequence via Allene Intermediates: Metal-Free Construction of 2,3-Dihydroindenes and Isoindolines
2016, Advanced Synthesis and Catalysis
Synthesis and spectral properties of photochromic cyclopentenone diarylethenes with an additional π system in the ethene bridge
2013, Mendeleev Communications
N-Halosuccinimide/SiCl<inf>4</inf> as general, mild and efficient systems for the α-monohalogenation of carbonyl compounds and for benzylic halogenation
2011, Tetrahedron Letters

View all citing articles on Scopus

View full text

Synthesis of phosphonate derivatives of 2,3-dihydroindene

Abstract

Graphical abstract

Tetrahedron Lett.

Bioorg. Med. Chem.

Pure Appl. Chem.

Bioorg. Med. Chem. Lett.

Acta Pharm.

J. Am. Chem. Soc.

J. Braz. Chem. Soc.

J. Org. Chem.

Synlett

Synthesis

ARKIVOC